Completed OBSERVATIONAL NCT04825834

DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study) (DELFI-L101)

Sponsor: Delfi Diagnostics Inc.

Conditions Bladder Cancer Colorectal Cancer Esophageal Cancer Head and Neck Cancer Kidney Cancer Liver Cancer Lung Cancer Pancreas Cancer Skin Cancer Stomach Cancer

Interventions Blood Sample Collection

Updated 11 times since 2021 Last updated: Aug 5, 2025 Started: Mar 22, 2021 Primary completion: Jul 15, 2025 Completion: Jul 15, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Bladder Cancer and Colorectal Cancer, this trial is completed. The trial is conducted by Delfi Diagnostics Inc. and has accumulated 11 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

11 versions recorded

Sep 2025 — Present [monthly]

Completed

Status: Active Not Recruiting → Completed
Aug 2025 — Sep 2025 [monthly]

Active Not Recruiting

Status: Recruiting → Active Not Recruiting
Sep 2024 — Aug 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Dec 2023 — Jul 2024 [monthly]

Recruiting

▶ Show 6 earlier versions

Dec 2022 — Dec 2023 [monthly]

Recruiting
Jul 2022 — Dec 2022 [monthly]

Recruiting
Apr 2022 — Jul 2022 [monthly]

Recruiting
Dec 2021 — Apr 2022 [monthly]

Recruiting
Sep 2021 — Dec 2021 [monthly]

Recruiting
May 2021 — Sep 2021 [monthly]

Recruiting

First recorded

Mar 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Delfi Diagnostics Inc.

Data source: Delfi Diagnostics Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Austin, United States , Boston, United States , Burlingame, United States , Champaign, United States , Chapel Hill, United States , Charleston, United States , Cincinnati, United States , Clearwater, United States , Cleveland, United States , Colorado Springs, United States and 43 more locations